Social media

On December 8-10 at CVCT, speak with our cardio-metabolic drug development experts about how we’re helping to address the challenges of CV trials and improve outcomes through more efficient trial design, effective use of...

On December 8-10 at CVCT, speak with our cardio-metabolic drug development experts about how we’re helping to address the challenges of CV trials and improve outcomes through more efficient trial design, effective use of...

Join ICON for “Science on Tap” — an evening of discovery, discussion, and holiday cheer! Explore cutting-edge research in precision medicine and bioanalytical laboratory innovation with our expert scientists. If you ar...

Join ICON for “Science on Tap” — an evening of discovery, discussion, and holiday cheer! Explore cutting-edge research in precision medicine and bioanalytical laboratory innovation with our expert scientists. If you ar...

High-risk medical devices and IVDs enter the JCA process in 2026. Are you prepared for what’s next? ICON’s whitepaper outlines what developers need to know—now. Read more: https://ow.ly/2wWF50XgHL8 #MedTech #IVD #JCA #H...

High-risk medical devices and IVDs enter the JCA process in 2026. Are you prepared for what’s next? ICON’s whitepaper outlines what developers need to know—now. Read more: https://ow.ly/2wWF50XgHL8 #MedTech #IVD #JCA #H...

15+ years of healthcare data. Weekly and monthly. Metys®, from Symphony Health, and ICON plc company, gives you unmatched historical depth to track product trends, market shifts, and lifecycle performance with precisio...

15+ years of healthcare data. Weekly and monthly. Metys®, from Symphony Health, and ICON plc company, gives you unmatched historical depth to track product trends, market shifts, and lifecycle performance with precisio...

ICH GCP E6(R3): The Future Starts Now The final version of ICH GCP E6(R3) is here—and it’s changing the way we design and conduct clinical trials. ICON’s regulatory experts will guide you through what’s new, what’s crit...

ICH GCP E6(R3) is here. Are you ready to lead the change? The global clinical research landscape is evolving and ICON is at the forefront. Join our upcoming Xtalks webinar to explore the impact, assess the risk and defi...

In today’s data-rich healthcare landscape, open claims datasets offer unmatched breadth and timeliness. But disruptions—whether from new sources or supplier exits—are inevitable. Join Symphony Health, an ICON plc compan...

Open claims datasets are a goldmine for life sciences—but they come with inevitable disruptions. Whether it’s new data sources or supplier exits, knowing how to manage change is key to maintaining strategic advantage. J...